SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-11-005615
Filing Date
2011-02-08
Accepted
2011-02-08 15:06:47
Documents
12
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q a11-5237_110q.htm 10-Q 727293
2 EX-10.1 a11-5237_1ex10d1.htm EX-10.1 262185
3 EX-10.2 a11-5237_1ex10d2.htm EX-10.2 59439
4 EX-10.3 a11-5237_1ex10d3.htm EX-10.3 60941
5 EX-10.4 a11-5237_1ex10d4.htm EX-10.4 60520
6 EX-10.5 a11-5237_1ex10d5.htm EX-10.5 68274
7 EX-10.6 a11-5237_1ex10d6.htm EX-10.6 68092
8 EX-10.7 a11-5237_1ex10d7.htm EX-10.7 68126
9 EX-10.8 a11-5237_1ex10d8.htm EX-10.8 64614
10 EX-31.1 a11-5237_1ex31d1.htm EX-31.1 12965
11 EX-31.2 a11-5237_1ex31d2.htm EX-31.2 12997
12 EX-32 a11-5237_1ex32.htm EX-32 7773
  Complete submission text file 0001104659-11-005615.txt   1474804
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
IMMUNOGEN INC (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-17999 | Film No.: 11582256
SIC: 2834 Pharmaceutical Preparations